
### [MONDO:0005515](http://purl.obolibrary.org/obo/MONDO_0005515)
**Label:** oral cavity cancer

**Subclasses:** [MONDO:0021431](http://purl.obolibrary.org/obo/MONDO_0021431) (squamous cell carcinoma of buccal mucosa), [MONDO:0005507](http://purl.obolibrary.org/obo/MONDO_0005507) (gingival cancer), [MONDO:0021279](http://purl.obolibrary.org/obo/MONDO_0021279) (mucoepidermoid carcinoma of submandibular gland), [MONDO:0003602](http://purl.obolibrary.org/obo/MONDO_0003602) (intracranial liposarcoma), [MONDO:0004615](http://purl.obolibrary.org/obo/MONDO_0004615) (upper gum cancer), [MONDO:0003600](http://purl.obolibrary.org/obo/MONDO_0003600) (cutaneous liposarcoma), [MONDO:0006834](http://purl.obolibrary.org/obo/MONDO_0006834) (lip cancer), [MONDO:0002634](http://purl.obolibrary.org/obo/MONDO_0002634) (liposarcoma of bone), [MONDO:0021316](http://purl.obolibrary.org/obo/MONDO_0021316) (malignant tumor of minor salivary gland), [MONDO:0003601](http://purl.obolibrary.org/obo/MONDO_0003601) (mediastinum liposarcoma), [MONDO:0006436](http://purl.obolibrary.org/obo/MONDO_0006436) (submandibular gland adenoid cystic carcinoma), [MONDO:0004611](http://purl.obolibrary.org/obo/MONDO_0004611) (soft palate cancer), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0006435](http://purl.obolibrary.org/obo/MONDO_0006435) (submandibular gland adenocarcinoma), [MONDO:0006358](http://purl.obolibrary.org/obo/MONDO_0006358) (parotid gland squamous cell carcinoma), [MONDO:0006357](http://purl.obolibrary.org/obo/MONDO_0006357) (parotid gland carcinoma ex pleomorphic adenoma), [MONDO:0006356](http://purl.obolibrary.org/obo/MONDO_0006356) (parotid gland adenoid cystic carcinoma), [MONDO:0006355](http://purl.obolibrary.org/obo/MONDO_0006355) (parotid gland acinic cell carcinoma), [MONDO:0000371](http://purl.obolibrary.org/obo/MONDO_0000371) (oral cavity carcinoma in situ), [MONDO:0006073](http://purl.obolibrary.org/obo/MONDO_0006073) (adenomatoid odontogenic tumor), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0021070](http://purl.obolibrary.org/obo/MONDO_0021070) (sublingual gland carcinoma), [MONDO:0021429](http://purl.obolibrary.org/obo/MONDO_0021429) (squamous cell carcinoma of floor of mouth), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0004669](http://purl.obolibrary.org/obo/MONDO_0004669) (salivary gland cancer), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0004667](http://purl.obolibrary.org/obo/MONDO_0004667) (sublingual gland cancer), [MONDO:0004700](http://purl.obolibrary.org/obo/MONDO_0004700) (parotid gland cancer), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0006405](http://purl.obolibrary.org/obo/MONDO_0006405) (salivary gland small cell carcinoma), [MONDO:0000545](http://purl.obolibrary.org/obo/MONDO_0000545) (sublingual gland adenoid cystic carcinoma), [MONDO:0004624](http://purl.obolibrary.org/obo/MONDO_0004624) (uvula cancer), [MONDO:0006404](http://purl.obolibrary.org/obo/MONDO_0006404) (salivary gland large cell carcinoma), [MONDO:0004621](http://purl.obolibrary.org/obo/MONDO_0004621) (upper lip cancer), [MONDO:0005238](http://purl.obolibrary.org/obo/MONDO_0005238) (round cell liposarcoma), [MONDO:0006403](http://purl.obolibrary.org/obo/MONDO_0006403) (salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006402](http://purl.obolibrary.org/obo/MONDO_0006402) (salivary gland basal cell adenocarcinoma), [MONDO:0006401](http://purl.obolibrary.org/obo/MONDO_0006401) (salivary gland adenosquamous carcinoma), [MONDO:0003175](http://purl.obolibrary.org/obo/MONDO_0003175) (salivary gland adenoid cystic carcinoma), [MONDO:0006286](http://purl.obolibrary.org/obo/MONDO_0006286) (major salivary gland mucoepidermoid carcinoma), [MONDO:0006285](http://purl.obolibrary.org/obo/MONDO_0006285) (major salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006284](http://purl.obolibrary.org/obo/MONDO_0006284) (major salivary gland carcinoma), [MONDO:0021538](http://purl.obolibrary.org/obo/MONDO_0021538) (verrucous carcinoma of oral cavity), [MONDO:0004719](http://purl.obolibrary.org/obo/MONDO_0004719) (hard palate cancer), [MONDO:0021333](http://purl.obolibrary.org/obo/MONDO_0021333) (carcinoma of lip), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0004958](http://purl.obolibrary.org/obo/MONDO_0004958) (oral squamous cell carcinoma), [MONDO:0004713](http://purl.obolibrary.org/obo/MONDO_0004713) (lower gum cancer), [MONDO:0004636](http://purl.obolibrary.org/obo/MONDO_0004636) (lip carcinoma in situ), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003589](http://purl.obolibrary.org/obo/MONDO_0003589) (liposarcoma of the ovary), [MONDO:0021339](http://purl.obolibrary.org/obo/MONDO_0021339) (carcinoma of hard palate), [MONDO:0003587](http://purl.obolibrary.org/obo/MONDO_0003587) (pediatric liposarcoma), [MONDO:0003389](http://purl.obolibrary.org/obo/MONDO_0003389) (epithelial-myoepithelial carcinoma), [MONDO:0003588](http://purl.obolibrary.org/obo/MONDO_0003588) (larynx liposarcoma), [MONDO:0003585](http://purl.obolibrary.org/obo/MONDO_0003585) (adult liposarcoma), [MONDO:0004631](http://purl.obolibrary.org/obo/MONDO_0004631) (tongue cancer), [MONDO:0003586](http://purl.obolibrary.org/obo/MONDO_0003586) (esophagus liposarcoma), [MONDO:0004510](http://purl.obolibrary.org/obo/MONDO_0004510) (inflammatory liposarcoma), [MONDO:0006213](http://purl.obolibrary.org/obo/MONDO_0006213) (floor of mouth mucoepidermoid carcinoma), [MONDO:0004673](http://purl.obolibrary.org/obo/MONDO_0004673) (lower lip cancer), [MONDO:0021331](http://purl.obolibrary.org/obo/MONDO_0021331) (carcinoma of parotid gland), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0021329](http://purl.obolibrary.org/obo/MONDO_0021329) (carcinoma of soft palate), [MONDO:0004727](http://purl.obolibrary.org/obo/MONDO_0004727) (vestibule of mouth cancer), [MONDO:0004724](http://purl.obolibrary.org/obo/MONDO_0004724) (submandibular gland cancer), [MONDO:0000521](http://purl.obolibrary.org/obo/MONDO_0000521) (salivary gland carcinoma), [MONDO:0021009](http://purl.obolibrary.org/obo/MONDO_0021009) (salivary gland mucoepidermoid carcinoma), [MONDO:0004645](http://purl.obolibrary.org/obo/MONDO_0004645) (cheek mucosa cancer), [MONDO:0021280](http://purl.obolibrary.org/obo/MONDO_0021280) (mucoepidermoid carcinoma of parotid gland), [MONDO:0003599](http://purl.obolibrary.org/obo/MONDO_0003599) (vulvar liposarcoma), [MONDO:0003596](http://purl.obolibrary.org/obo/MONDO_0003596) (spindle cell liposarcoma), [MONDO:0003597](http://purl.obolibrary.org/obo/MONDO_0003597) (mixed-type liposarcoma), [MONDO:0003594](http://purl.obolibrary.org/obo/MONDO_0003594) (mixed liposarcoma), [MONDO:0003592](http://purl.obolibrary.org/obo/MONDO_0003592) (gastric liposarcoma), [MONDO:0003593](http://purl.obolibrary.org/obo/MONDO_0003593) (breast liposarcoma), [MONDO:0004682](http://purl.obolibrary.org/obo/MONDO_0004682) (retromolar area cancer), [MONDO:0003590](http://purl.obolibrary.org/obo/MONDO_0003590) (fibroblastic liposarcoma), [MONDO:0003591](http://purl.obolibrary.org/obo/MONDO_0003591) (kidney liposarcoma), 

**Mapped go classes:** [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), 

**Class expressions from DL-Learner:**

- [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex) 66.67%
- [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex) 66.67%
- [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex) 66.67%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) 55.75%
- [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex) 55.69%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 54.50%
- [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex) 53.75%
- [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex) 53.75%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 53.22%
- Thing 51.11%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 39.21%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 37.30%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 37.10%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 36.57%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 36.14%


